logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Tachycardia Ventricular

    FiltersReset Filters
    12 results

    • amiodarone hydrochloride

      (Amiodarone Hydrochloride)
      Chartwell RX, LLC
      Usage: Amiodarone hydrochloride is indicated for treating documented life-threatening recurrent ventricular fibrillation and hemodynamically unstable tachycardia in adults unresponsive to other antiarrhythmics or when alternative medications are intolerable.

    • amiodarone hydrochloride

      (amiodarone hydrochloride)
      Zhejiang Poly Pharm. Co., Ltd.
      Usage: Amiodarone injection is indicated for the initiation of treatment and prevention of recurrent ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients unresponsive to other therapies. It can also be used for patients needing oral therapy but unable to take oral medication, facilitating a transition to oral amiodarone.

    • amiodarone hydrochloride

      (amiodarone hydrochloride)
      Hainan Poly Pharm. Co., Ltd.
      Usage: Amiodarone injection is indicated for treating and preventing frequently recurring ventricular fibrillation (VF) and unstable ventricular tachycardia (VT) in patients unresponsive to other treatments. It is also suitable for patients who require oral amiodarone but cannot take oral medication during their acute treatment.

    • amiodarone hydrochloride

      (Amiodarone Hydrochloride)
      Aurobindo Pharma Limited
      Usage: Amiodarone hydrochloride tablets are indicated for treating documented, life-threatening recurrent ventricular fibrillation and hemodynamically unstable tachycardia in adults unresponsive to other antiarrhythmics or when alternative treatments are not tolerated.

    • diltiazem hydrochloride

      (Diltiazem Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Diltiazem Hydrochloride Injection is indicated for temporary control of rapid ventricular rates in atrial fibrillation or flutter and for converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. Continuous monitoring is essential during administration, with emergency equipment on hand.

    • flecainide acetate

      (Flecainide Acetate)
      Amneal Pharmaceuticals LLC
      Usage: Flecainide is indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It is also used for documented life-threatening ventricular arrhythmias. Its use is contraindicated in patients with recent myocardial infarction and chronic atrial fibrillation is not recommended.

    • propafenone hcl

      (Propafenone hydrochloride)
      Actavis Pharma, Inc.
      Usage: Propafenone hydrochloride is indicated to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter and supraventricular tachycardia in patients without structural heart disease, and to treat life-threatening ventricular arrhythmias. It should be initiated in a hospital setting and is not recommended for patients with chronic atrial fibrillation.

    • propafenone hydrochloride

      (PROPAFENONE HYDROCHLORIDE)
      Aurobindo Pharma Limited
      Usage: Propafenone hydrochloride is indicated for prolonging the time to recurrence of paroxysmal atrial fibrillation/flutter and paroxysmal supraventricular tachycardia in patients without structural heart disease, and for treating life-threatening ventricular arrhythmias. Its use in chronic atrial fibrillation and for lesser ventricular arrhythmias is not recommended.

    • verapamil hydrochloride

      (verapamil hydrochloride)
      Lifestar Pharma LLC
      Usage: Verapamil Hydrochloride Injection, USP is indicated for rapid conversion to sinus rhythm in paroxysmal supraventricular tachycardias and for temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation. It should be administered in a monitored setting due to potential life-threatening adverse effects.

    • verapamil hydrochloride

      (Verapamil Hydrochloride)
      Zydus Pharmaceuticals USA Inc.
      Usage: Verapamil hydrochloride injection is indicated for rapid conversion to sinus rhythm in paroxysmal supraventricular tachycardias and for temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation, particularly in patients not associated with accessory bypass tracts. Monitoring during administration is advised due to potential serious adverse effects.